1983;11:6883C6894. of HPrEpiC as healthy and 99% of LNCaP cells as cancer-like, recognized a majority of aberrant cells within histopathologically benign cells at baseline analysis
Structure-Based Design of mTORC1 Inhibitors in Cancer Therapy
mTORC1 inhibitor